Statement on Covid-19
A message to our healthcare providers and patients during the COVID-19 pandemic
At Radius Health, safety and well-being remain our highest priority. In response to the spread of COVID-19, we are addressing the issue with the seriousness it deserves and taking measures to help ensure the health of our employees, the healthcare providers (HCPs) and patients we serve, and their families and communities.
We have taken several measures to ensure patients and HCPs continue to have access to our medicine and available resources. Outlined below are some of these virtual measures and related important information.
As a reminder, TYMLOS® (abaloparatide) injection is a self-injectable and does not require patients to return to the office for treatment. Additionally, TYMLOS is generally dispensed by specialty pharmacies who ship prescriptions via mail, so patients served by them may be able to avoid traveling to their local pharmacy to refill prescriptions.
We are also offering virtual representative interactions to connect with health care professionals and assist their offices with continued access to TYMLOS tools and resources. Additionally, we have expanded our clinical educator team to deliver virtual injection support to our patients. Operationally, we have implemented online processes to supply samples and promotional material to HCP offices.
As the global COVID-19 pandemic evolves, we are giving careful attention to the supply of TYMLOS and our investigational products. It’s important to note that our supply chain for TYMLOS is mostly located in Europe and we currently believe we have sufficient inventory on hand. In addition, we also currently believe we have sufficient inventories of our investigational products, abaloparatide-patch and elacestrant (RAD1901), to support our ongoing clinical trials. We are working closely with our contract manufacturing organizations to mitigate risks to our continuity of supply.
For additional information regarding Radius products, visit: https://radiuspharm.com/contact/
Please see the full prescribing information here